Listed on OSE
BergenBio`s Bemcentinib now in
UK financed Covid-19 studym, Fast track ACCORD.
Number og study ongoing: 15
* ACCORD Covid-19
* Bemcentinib/Keytruda combo whit Merck i NSCLC.
9 of 15 sponsored studies.
Tecnicaly potent, whit big upside potential. Fair value at the moment 86nok. Archtic Securities.